Granahan Investment Management’s HTG Molecular Diagnostics, Inc. Common Stock HTGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-4,472
| Closed | -$1.34M | – | 191 |
|
|
2019
Q2 | $1.34M | Sell |
4,472
-90
| -2% | -$26.9K | 0.07% | 160 |
|
|
2019
Q1 | $2.05M | Sell |
4,562
-573
| -11% | -$258K | 0.11% | 149 |
|
|
2018
Q4 | $2.35M | Sell |
5,135
-94
| -2% | -$43K | 0.17% | 122 |
|
|
2018
Q3 | $4.75M | Buy |
5,229
+143
| +3% | +$130K | 0.26% | 104 |
|
|
2018
Q2 | $2.98M | Buy |
5,086
+628
| +14% | +$368K | 0.18% | 135 |
|
|
2018
Q1 | $2.91M | Buy |
4,458
+1,806
| +68% | +$1.18M | 0.21% | 129 |
|
|
2017
Q4 | $969K | Buy |
2,652
+338
| +15% | +$124K | 0.08% | 167 |
|
|
2017
Q3 | $708K | Buy |
2,314
+1,921
| +489% | +$588K | 0.06% | 162 |
|
|
2017
Q2 | $188K | Buy |
393
+210
| +115% | +$100K | 0.02% | 223 |
|
|
2017
Q1 | $228K | Buy |
+183
| New | +$228K | 0.02% | 207 |
|